Application of serum protein fingerprint in diagnosis of papillary thyroid carcinoma

被引:37
作者
Wang, Jia-Xiang
Yu, Jie-kai
Wang, Li
Liu, Qiu-Liang
Zhang, Jiao
Zheng, Shu
机构
[1] Zhejiang Univ, Inst Canc, Affiliated Hosp 2, Coll Med, Hangzhou 310027, Zhejiang P, Peoples R China
[2] Zhengzhou Univ, Dept Surg, Affiliated Hosp 1, Zhengzhou, Henang P, Peoples R China
[3] Zhejiang Univ, Coll Life Sci, Hangzhou 310009, Zhejiang P, Peoples R China
关键词
diagnosis; protein profile; support vector machine; surface-enhanced laser desorption/ionization; thyroid carcinoma;
D O I
10.1002/pmic.200500833
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
To find new biomarkers and establish serum protein fingerprint models for early diagnosis and preoperative staging of papillary thyroid carcinoma, we employed SELDI-TOF-MS and bioinformatics tools. A total of 116 samples were analyzed in this study. The first 80 samples were analyzed by SELDI-TOF-MS and two biomarker patterns were identified. Pattern 1 distinguishes patients with papillary thyroid carcinoma from healthy individuals. Pattern 2 distinguishes papillary thyroid carcinoma from benign thyroid nodes. The remaining 29 samples were analyzed on the second day and served as an independent test set. The analysis of this independent test set yielded a specificity of 80.0% and a sensitivity of 88.9% for pattern 1 and a specificity of 80.0% and a sensitivity of 80.0% for pattern 2. Two additional biomarker patterns were identified to distinguish different stages of the papillary thyroid carcinoma (pattern 3) with an accuracy of 77.1% and different pathological types of thyroid carcinoma (pattern 4) with an accuracy of 88.1%. Taken together, the SELDI-TOF-MS technique combined with bioinformatics approaches can not only facilitate the discovery of better biomarkers for papillary thyroid carcinoma but also provide a useful tool for molecular diagnosis in the future.
引用
收藏
页码:5344 / 5349
页数:6
相关论文
共 32 条
  • [1] Adam BL, 2002, CANCER RES, V62, P3609
  • [2] Byvatov Evgeny, 2003, Appl Bioinformatics, V2, P67
  • [3] Artificial neural networks analysis of surface-enhanced laser desorption/ionization mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population
    Chen, YD
    Zheng, S
    Yu, JK
    Hu, X
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (24) : 8380 - 8385
  • [4] The application of clinical proteomics to cancer and other diseases
    Clarke, W
    Zhang, Z
    Chan, DW
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, 41 (12) : 1562 - 1570
  • [5] Support vector machine classification and validation of cancer tissue samples using microarray expression data
    Furey, TS
    Cristianini, N
    Duffy, N
    Bednarski, DW
    Schummer, M
    Haussler, D
    [J]. BIOINFORMATICS, 2000, 16 (10) : 906 - 914
  • [6] SELDI-TOF-MS: the proteomics and bioinformatics approaches in the diagnosis of breast cancer
    Hu, Y
    Zhang, SZ
    Yu, JK
    Liu, J
    Zheng, S
    [J]. BREAST, 2005, 14 (04) : 250 - 255
  • [7] Role of Proteomics in Diagnosis of Cancer
    Jain, K. K.
    [J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2002, 1 (04) : 281 - 286
  • [8] Virtual screening of molecular databases using a Support Vector Machine
    Jorissen, RN
    Gilson, MK
    [J]. JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2005, 45 (03) : 549 - 561
  • [9] Laronga C, 2003, DIS MARKERS, V19, P229
  • [10] Serum protein fingerprinting coupled with artificial neural network distinguishes glioma from healthy population or brain benign tumor
    Liu J.
    Zheng S.
    Yu J.-K.
    Zhang J.-M.
    Chen Z.
    [J]. Journal of Zhejiang University-SCIENCE B, 2005, 6 (1): : 4 - 10